These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8324649)
21. Being a modern pharmaceutical company: new paradigms for the pharmaceutical industry. Hassan F Clin Pharmacol Ther; 2001 May; 69(5):281-5. PubMed ID: 11371995 [No Abstract] [Full Text] [Related]
22. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France. Napper AD IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316 [No Abstract] [Full Text] [Related]
23. The power of genomics to transform the biotechnology industry. Haseltine WA Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259 [No Abstract] [Full Text] [Related]
24. The evolving role of collaboration in biotechnology. Gower JM Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261 [No Abstract] [Full Text] [Related]
26. New drug development in the United States from 1963 to 1990. DiMasi JA; Bryant NR; Lasagna L Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):471-86. PubMed ID: 1934860 [No Abstract] [Full Text] [Related]
27. Emerging unscathed? Gershell LJ; Miller TA Nat Rev Drug Discov; 2002 Sep; 1(9):739. PubMed ID: 12216577 [No Abstract] [Full Text] [Related]
28. Emerging trends in biotechnology: a perspective from the pharmaceutical industry. Szkrybalo W Pharm Res; 1987 Oct; 4(5):361-3. PubMed ID: 3508545 [No Abstract] [Full Text] [Related]
29. A European perspective on regulation and technology. Sharp J PDA J Pharm Sci Technol; 1997; 51(3):104-10. PubMed ID: 9203822 [No Abstract] [Full Text] [Related]
30. New drug development in the United States from 1963 to 1999. Dimasi JA Clin Pharmacol Ther; 2001 May; 69(5):286-96. PubMed ID: 11371996 [No Abstract] [Full Text] [Related]
36. Designer drugs: the evolving science of drug discovery. Wanke LA; DuBose RF Pharm Pract Manag Q; 1998 Jul; 18(2):13-22. PubMed ID: 10185235 [TBL] [Abstract][Full Text] [Related]
37. New pharma-biotech company formation in India. Saberwal G Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124 [No Abstract] [Full Text] [Related]
38. BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA. Xu J IDrugs; 2004 Sep; 7(9):841-5. PubMed ID: 15470601 [TBL] [Abstract][Full Text] [Related]
39. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser. Valenzano KJ Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548 [No Abstract] [Full Text] [Related]
40. Shaking Up Biotech/Pharma: Can Cues Be Taken from the Tech Industry? Wang CK SLAS Technol; 2017 Jun; 22(3):233-236. PubMed ID: 28298148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]